News & Updates

Infants born to mothers who are very young or those with advanced age are at increased risk of nonchromosomal congenital anomalies (NCAs), according to the results of a meta-analysis.

There appears to be a downward trend in the prevalence of antibodies against cytomegalovirus (CMV) among pregnant women in Singapore, raising concerns about the potential increase in the proportion of this population who face increased susceptibility to primary CMV infection during pregnancy, as shown in a study.

Women with vasculitis who get pregnant can deliver live births at term, although flares or hospitalization due to vasculitis may occur during pregnancy, according to a study.

Hidradenitis suppurativa (HS) poses increased risk of adverse maternal and offspring outcomes not only during the peripartum period but also in the long term, according to a study.

In early to mid-pregnancy, low or excessively high maternal serum folate levels carry a heightened risk of congenital heart disease (CHD) in the offspring, as shown in a study.

New drug applications approved by US FDA as of 1-15 October 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

High sperm deoxyribonucleic acid fragmentation index (DFI) level appears to negatively affect the outcome of pregnancies achieved with assisted reproductive technology (ART), being linked to increased risks of complications such as preterm birth and pre-eclampsia in a new research.